We analyzed plasma and found increased calprotectin (S100A8/A9, a marker of neutrophil activation) and NETs (measured as MPO-DNA complexes) in SSc patients as compared to healthy controls (Fig. 1A-B). This evidence concerns the gene S100A8 and systemic sclerosis.